Location History:
- Quebec, CA (2010)
- Pincourt, CA (2006 - 2017)
- Montreal, CA (2016 - 2017)
Company Filing History:
10 out of 24 
10 out of 22 
1 out of 1 Years Active: 2006-2017
Title: **James B. Jaquith: Innovator in Protein Kinase Inhibitors**
Introduction
James B. Jaquith is an accomplished inventor based in Montreal, Canada, known for his significant contributions to the field of biochemistry and pharmaceuticals. With a remarkable portfolio of 21 patents, Jaquith has focused on developing novel inhibitors that target protein kinases, which are crucial in various cellular processes.
Latest Patents
Among his latest inventions, Jaquith has developed selective inhibitors of the Tec and Src protein kinase families. These groundbreaking patents relate to a novel family of inhibitors designed to disrupt the activity of these vital kinases. In one specific embodiment, these inhibitors are described by Formula 1. Another of his significant innovations involves protein kinase inhibitors that encompass a broader range, including members from the Tec, Src, Btk, and Lck families. This invention also highlights a process for producing these inhibitors and includes pharmaceutical compositions for potential therapeutic use.
Career Highlights
Throughout his career, Jaquith has held significant positions in leading pharmaceutical companies. Notably, he has worked with Aegera Therapeutics, Inc. and Pharmascience Inc., where he contributed to research and development efforts aimed at creating impactful therapeutic solutions. His unrelenting pursuit of innovation has positioned him as a notable inventor in his field.
Collaborations
James B. Jaquith has collaborated with talented professionals, including Alain Laurent and Alain Boudreault, who have also made strides in the pharmaceutical industry. These collaborations have played a crucial role in enhancing the research and development of novel therapeutic agents.
Conclusion
In conclusion, James B. Jaquith stands out as a prominent figure in the field of protein kinase research. His innovative spirit and dedication to developing new therapeutic approaches continue to influence the pharmaceutical landscape, making him a pivotal contributor to advancements in medical science.